Loading...
Loading...
Oppenheimer maintained its Ceragon Networks
CRNT Outperform rating and $12 price target in a research report published today.
In the report, Oppenheimer stated, "VIT reported better than expected 4Q11 revenue of $87.2M, but EPS of $0.20 slightly missed our projection due to weaker than expected margins that declined Y/Y and Q/Q. For 2012, VIT guided revenue to grow at least 27.1% Y/Y to $360M and EPS to $0.86-$0.92."
Shares of Ceragon Networks closed today at $9.11, down 2.15% from Monday's market close.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We simplify the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in